Kelyniam Global, Inc.

Kelyniam Global, Inc.

KLYG - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.01M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Kelyniam Global, Inc.Kelyniam Global, Inc.-100--5%-0.7
$-0.02

Current Fair Value

127.3% downside

Overvalued by 127.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5.01 Million
Enterprise Value$5.49 Million
Earnings per Share$0
Beta-0.1
Outstanding Shares50,923,430

Return

Return on Equity-5.48%ROE
Return on Assets-2.21%
Return on Invested Capital31.84%

Valuation & Multiples

P/E Ratio-100P/E Ratio
PEG95.58PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue1.44
Enterprise Value to EBIT18.85
Enterprise Value to Net Income-138
Total Debt to Enterprise0.09
Debt to Equity0.69Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Kelyniam Global, Inc.

9 employees
CEO: Ross Bjella

Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced...